GlassScriptPhysician profile
David M Lavine
NPI 1407816408
$12,970.77
in general payments reported to CMS, 2019-2025
6 companies · $301 in 2025
The $301 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,119 · 2020: $2,186 · 2021: $2,000 · 2022: $2,000 · 2023: $2,000 · 2024: $2,364 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $4,343 · Food and Beverage: $322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $4,342.63 |
| Food and Beverage | $322.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $12,342.63 | 2019-2024 | |
| Sientra, INC. | $169.73 | 2020 | |
| Davol INC. | $150.88 | 2025 | |
| Abbvie INC. | $149.82 | 2025 | |
| Allergan, INC. | $119.45 | 2019 | |
| Pfizer INC. | $38.26 | 2020-2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lavine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.